Locations:

Blood Cancers

March 29, 2019/Cancer/Blood Cancers

National Data Show Misdiagnoses Common for Patients with Myelodysplastic Syndromes

Preliminary results from a national registry

March 25, 2019/Cancer/Blood Cancers

Azacitidine Shows Potential in Treating AML and MDS Relapse Following Stem Cell Transplantation

May offer much needed treatment option for patients who relapse early

March 19, 2019/Cancer/Blood Cancers

Maintenance Rituximab Extends Remission in Pretreated Patients with Follicular Lymphoma

Patients in partial remission improve further

March 11, 2019/Cancer/Blood Cancers

R-EPOCH May Extend Survival in Patients with Rare Forms of Diffuse Large B-Cell Lymphoma

Prospective study shows improved outcomes

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 8, 2019/Cancer/Blood Cancers

Mutation Clonal Burden and Transplantation Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Some mutations associated with higher risk of relapse

February 21, 2019/Cancer/Blood Cancers

Three Targeted Agents in Development for Molecular Subtypes of Leukemia

Investigators making strides in cancer drug discovery

February 13, 2019/Cancer/Blood Cancers

Personalized Survivorship Care Plans Reduce Distress, Improve QOL in HCT Survivors

Plans generated from readily available data

January 24, 2019/Cancer/Blood Cancers

Additions to R-CHOP in Patients with Diffuse or Aggressive Large B-Cell Lymphoma

Genetics affect how patients respond

January 14, 2019/Cancer/Blood Cancers

Graft Composition in Allogeneic Hematopoietic Cell Transplantation May Be Associated with Patient Outcomes

A closer look at other T-cell subsets

November 28, 2018/Cancer/Blood Cancers

New Drug Approved to Treat Some Patients with Acute Myeloid Leukemia

Response rates as good as or better than other therapies

BackPage 5 of 8Next